FDA advisory committee for peptides stocked with conflicts of interest

The FDA has listed its advisory members for the committee that will discuss peptides in late July. Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some of the most transformative drugs in modern medicine are peptides,” including insulin and semaglutide. While “the science of peptides is real, serious and worth

Raccontata damedpagetoday.comstatnews.comapnews.comcnn.comendpoints.newsarstechnica.comhealio.com